Web Analytics

3 Latest Announced Rounds

  • $100,000,000
    Unknown

    7 Investors

    Computers and Electronics Manufacturing
    Jun 3rd, 2025
  • $24,000,000
    Unknown

    5 Investors

    Software Development
    Jun 3rd, 2025
  • $5,500,000
    Seed

    4 Investors

    Software Development
    Jun 3rd, 2025
$777.21M Raised in 57 Funding Rounds in the past 7 Days - View All

Funding Round Profile

NewLimit

start up
United States - South San Francisco, California
  • 18/05/2023
  • Series A
  • $40,000,000

NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.


Related People

Blake ByersCo Founder

Blake Byers United States - San Francisco Bay Area

I build and invest in tech and biotech companies. I try to maintain excess capacity so I have time for the weird, fringe ideas that are often the way we positively shape the future.

https://www.byerscap.com/